Think of Etelcalcetide as an IV Alternative to Cinacalcet

February 2018

You'll see a new "calcimimetic," etelcalcetide (Parsabiv, PAR-sah-biv), for treating hyperparathyroidism in dialysis patients.

This condition is a vicious cycle.

Kidney failure leads to high phosphorous...which binds calcium. Low calcium triggers parathyroid hormone release...which boosts calcium, such as by pulling it from the GI tract and bones into blood. Phosphorous keeps binding calcium...which continues to trigger parathyroid hormone release.

Practical advice for a better career, with unlimited access to CE

Hospital Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Hospital Practice Act Fast When Dantrolene Is Needed for Malignant Hyperthermia
Med Histories Use Strategies to Hone Your Med History Skills
Analgesics Avoid Dangerous Mishaps With Local Anesthetics
Salt Forms Know Your Way Around Salt Forms
Med Safety Expect to See Less Use of Injectable Promethazine
Kidney Disease Think of Etelcalcetide as an IV Alternative to Cinacalcet
Critical Care You May Be Surprised by Meds Used in Targeted Temperature Management Protocols
HIV & AIDS Juluca Is the Latest Once-Daily Combo Med for HIV
Supplements Document Details of Supplement Use on Med Histories
Travel Medicine Be Aware of Treatments for Altitude Sickness
Diabetes Meds Know How Bydureon BCise, Ozempic, and Steglatro Compare to Other Diabetes Meds

Think of Etelcalcetide as an IV Alternative to Cinacalcet

Practical advice for a better career, with unlimited access to CE

Table of Contents